Circulating adiponectin concentrations are reduced in obese individuals, and this reduction has been proposed to play a crucial role in the pathogenesis of atherosclerosis and cardiovascular diseases associated with obesity and lipid metabolism [33]. Here, ADIPOQ is linked to cardiovascular disorder.